Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell) in Healthy Chinese Population Aged 40 Years and Older

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The objective of this study was to evaluate the safety, immunogenicity and immune persistence of recombinant herpes zoster vaccine (CHO cells) with different adjuvant doses in healthy people aged 40 years and older.
Epistemonikos ID: b3b02779fba188beea569f3194ef5858222e8b37
First added on: Mar 01, 2025